Electroconvulsive Seizures Regulate Gene Expression of Distinct Neurotrophic Signaling Pathways

Journal of Neuroscience

Volumn 24, Issue 11, 2004, Pages 2667-2677

  Altar, C Anthony ^a   Laeng, Pascal ^a   Jurata, Linda W ^a   Brockman, Jeffrey A ^a   Lemire, Andrew ^a   Bullard, Jeffrey ^a   Bukhman, Yury V ^a   Young, Theresa A ^a   Charles, Vinod ^a   Palfreyman, Michael G ^a  

^a Psychiatric Genomics Inc   (United States)

Author keywords

Bipolar disorder; Depression; ECS; Frontal cortex; Gene expression; Hippocampus; Microarray

Indexed keywords

ARACHIDONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE Y; PROTIRELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; EXERCISE RESPONSE GENE; FRONTAL CORTEX; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; MALE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RNA SEQUENCE; SEIZURE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ANIMALS; BEHAVIOR, ANIMAL; ELECTROSHOCK; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MODELS, ANIMAL; NERVE GROWTH FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 12144290112     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5377-03.2004     Document Type: Article

References (53)

1. Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20:59-61.
2. Altar CA, Whitehead RE, Chen R, Wortwein G, Madsen TR (2003) Effects of electroconvulsive seizure and antidepressants on BDNF protein content in brain. Biol Psych 54:703-709.
3. Austin MC, Whitehead RE, Edgar CL, Janosky JE, Lewis DA (2002) Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience 114:807-815.
4. Baik EJ, Kim EJ, Lee SH, Moon C (1999) Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res 843:118-129.
5. Barnea A, Roberts J (2001) Induction of functional and morphological expression of NPY in cortical cultures by BDNF: evidence for a requirement of ERK-dependent and ERK-independent mechanisms. Brain Res 919:57-69.
6. Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, Worley PF (1997) Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386:284-288.
7. Caberlotto L, Hurd YL (1999) Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. NeuroReport 10:1747-1750.
8. Caberlotto L, Fuxe K, Overstreet DH, Gerrard P, Hurd YL (1998) Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Mol Brain Res 59:58-65.
9. Chen AC, Shin KH, Duman RS, Sanacora G (2001) ECS-induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J ECT 17:27-32.
10. Davidson RJ, Lewis DA, Alloy LB, Amaral DG, Bush G, Cohen JD, Drevets WC, Farah MJ, Kagan J, McClelland JL, Nolen-Hoeksema S, Peterson BS (2002) Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 52:478-502.
11. Drago F, Pulvirenti L, Spadaro F, Pennisi G (1990) Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats. Psychoneuroendocrinology 15:349-356.
12. Drevets WC, Gadde K, Krishnan R (1999) Neuroimaging studies of depression. In: Neurobiology of mental illness (Charney DS, Nestler EJ, Bunney BJ, eds), pp 394-418. New York: Oxford UP.
13. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
14. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77:916-928.
15. Elliott RC, Miles MF, Lowenstein DH (2003) Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci 23:2218-2227.
16. Fochtmann LJ (1994) Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull 30:321-444.
17. Fujimori K, Fujitani Y, Kadoyama K, Kumanogoh H, Ishikawa K, Urade Y (2003) Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cells. J Biol Chem 278:6018-6026.
18. Hashimoto, K Watanabe, K-I, Nishimuara T, Iyo M, Shirayama Y, Minabe Y (1998) Behavioral changes and expression of heat shock protein hsp-70 mRNA, BDNF mRNA, and cyclooxygenase-2 mRNA in rat brain following seizures induce by systemic administration of kainic acid. Brain Res 804:212-223.
19. Hatzinger M, Holsboer-Trachsler E (1999) Therapy refractory depression. Wien Med Wocheschr 149:511-514.
20. Hellsten J, Wennstrom M, Mohapel P, Ekdahl CT, Bengzon J, Tingstrom A (2002) Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. Eur J Neurosci 16:283-290.
21. Hendriksen H, Katson NA, Ghijesen W, van Vilet EA, da Silva F, Gorter JA, Vreugdenhil E (2001) Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model. Eur J Neurosci 14:1475-1484.
22. Hill RD, Storandt M, Malley M (1993) The impact of long-term exercise training on psychological function in older adults. J Gerontol 48:12-17.
23. Iritani S, Kuroki N, Niizato K, Ikeda K (2000) Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 24:241-249.
24. Kageyama R, Ohtsuka T (1999) The Notch-Hes pathway in mammalian neural development. Cell Res 9:179-188.
25. Labbe EE, Welsh MC, Delaney D (1988) Effects of consistent aerobic exercise on the psychological functioning of women. Percept Mot Skills 67:919-925.
26. Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P (2002) Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry 159:1830-1840.
27. Lukasiuk K, Kontula L, Pitkane A (2003) cDNA profiling of epileptogenesis in the rat brain. Eur J Neurosci 17:271-279.
28. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A (2000) Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47:1043-1049.
29. Matzilevich DA, Rall JM, Moore AN, Grill RJ, Dash PK (2002) High-density microarray analysis of hippocampal gene expression following experimental brain injury. J Neurosci Res 67:646-663.
30. Mikkelsen JD, Woldbye D, Kragh J, Larsen PJ, Bolwig TG (1994) Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Brain Res Mol Brain Res 23:317-322.
31. Molteni R, Ying Z, Gomez-Pinnilla F (2002) Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur J Neurosci 16:107-116.
32. Nakamura S (1993) Involvement of phospholipase A2 in axonal regeneration of brain catecholamine neurons. NeuroReport 4:371-374.
33. Nakamura S (1994) Effects of phospholipase A2 inhibitors on the antidepressant-induced axonal regeneration of noradrenergic locus coeruleus neurons. Microsc Res Tech 29:204-210.
34. Newton S, Collier EF, Husberger J, Adams D, Terwilleger R, Selvanayagam E, Duman R (2003) Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23:10841-10851.
35. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
36. Ogawa N, Mizuno S, Mori A, Nikina I, Ota Z, Yamamoto M (1984) Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues. Peptides 5:743-746.
37. Palfreyman MG, Hook DJ, Klimczak LJ, Brockman JR, Evans DM, Altar CA (2002) Novel directions in antipsychotic target identification using gene arrays. Curr Drug Target CNS Neurol Disord 1:205-216.
38. Pekary AE, Meyerhoff JL, Sattin A (2000) Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum. Brain Res 884:174-183.
39. Rapoport SI, Bosetti F (2002) Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch Gen Psych 59:592-596.
40. Russo-Neustadt A, Beard RC, Cotman CW (1999) Exercise, antidepressant medications, and enhanced brain-derived neurotrophic factor expression. Neuropsychopharmacology 21:679-682.
41. Sandhya TL, Ong WY, Horrocks LA, Farooqui AA (1998) A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res 788:223-231.
42. Satin A (1999) The role of TRH and related peptides in the mechanism of action of ECT. J ECT 15:76-92.
43. Sato M, Suzuki K, Nakanishi S (2001) NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells. J Neurosci 21:3797-3805.
44. Skolnick P, Legutko B, Li X, Bymaster FP (2001) Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res 43:411-423.
45. Thomas U (2002) Modulation of synaptic signalling complexes by Homer proteins. J Neurochem 81:407-413.
46. Tong L, Shen H, Perreau VM, Balazs R, Cotman CW (2001) Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis 8:1046-1056.
47. Wahlestedt C, Blendy JA, Kellar KJ, Heilig M, Widerlov E, Ekman R (1990) Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res 507:65-68.
48. Westrin A, Ekman R, Traskman-Bendz L (1999) Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with recent suicide attempts. Eur Neuropsychopharmacol 9:205-211.
49. Xu R, Li X (2003) A comparison of parametric versus permutation methods with applications to general and temporal microarray gene expression data. Bioinformatics 19:1284-1289.
50. Yagami T, Nakazato H, Ueda K, Asakura K, Kuroda T, Hata S, Sakaeda T, Sakaguchi G, Itoh N, Hashimoto Y, Hiroshige T, Kambayashi Y (2003) Prostaglandin E(2) rescues cortical neurons from amyloid beta protein-induced apoptosis. Brain Res 959:328-335.
51. Zachrisson O, Balldin J, Ekman R, Naesh O, Rosengren L, Agren H, Blennow K (2000) No evident neuronal damage after electroconvulsive therapy. Psychiatry Res 96:157-165.
52. Zetterstrom TS, Pei Q, Grahame-Smith DG (1998) Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Mol Brain Res 57:106-110.
53. Zhang MQ (2002) Extracting functional information from microarrays: a challenge for functional genomics. Proc Natl Acad Sci USA 99:12509-12511.